Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
暂无分享,去创建一个
M. M. Taha | S. Abdelwahab | B. Sheikh | R. Abdullah | Eltayeb E. M. Eid | C. W. How | Umar Yagoub | M. Taha | Rashad El-Sunousi
[1] A. Rasedee,et al. Characterization and Cytotoxicity of Nanostructured Lipid Carriers Formulated With Olive Oil, Hydrogenated Palm Oil, and Polysorbate 80 , 2013, IEEE Transactions on NanoBioscience.
[2] F. Ahmad,et al. Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies. , 2013, Colloids and surfaces. B, Biointerfaces.
[3] G. Mustafa,et al. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study , 2012, International journal of nanomedicine.
[4] C. Lehr,et al. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[5] T. Cardoso,et al. Thymoquinone β-Cyclodextrin Nanoparticles System: A Preliminary Study , 2012 .
[6] F. Tanfani,et al. Characterization of thymoquinone binding to human α₁-acid glycoprotein. , 2012, Journal of pharmaceutical sciences.
[7] G. Sethi,et al. Thymoquinone: potential cure for inflammatory disorders and cancer. , 2012, Biochemical pharmacology.
[8] S. M. Faisal,et al. Acrylated vegetable oil nanoparticle as a carrier and controlled release of the anticancer drug-thymoquinone , 2012, 2012 International Conference on Enabling Science and Nanotechnology.
[9] Noha M. Shawky,et al. Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. , 2011, International immunopharmacology.
[10] M. E. Morales,et al. Lipid-based drug delivery systems for cancer treatment. , 2011, Current drug targets.
[11] D. Vohora,et al. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies. , 2011, Biomedical chromatography : BMC.
[12] K. M. Khawar,et al. Preliminary report on hepatic and cardiovascular risk assessment of automobile mechanics in Nigeria , 2011 .
[13] M. Werner,et al. Antiulcerogenic activity of hydroalcoholic extract of Achillea millefolium L.: involvement of the antioxidant system. , 2010, Journal of ethnopharmacology.
[14] B. Aggarwal,et al. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. , 2010, Biochemical pharmacology.
[15] R. Thiruganesh,et al. Solid lipid nanoparticle and nanoparticle lipid carrier for controlled drug delivery – a review of state of art and recent advances , 2010 .
[16] A. Pichette,et al. Bioactivities of black cumin essential oil and its main terpenes from Tunisia , 2010 .
[17] A. Abdul,et al. Validated high performance liquid chromatographic (HPLC) method for analysis of zerumbone in plasma , 2010 .
[18] N. Ismail,et al. Antioxidant activity and phenolic content of phenolic rich fractions obtained from black cumin (Nigella sativa) seedcake. , 2009 .
[19] V. Kadam,et al. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers. , 2008, Current drug delivery.
[20] Jia-You Fang,et al. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion , 2008, Acta Pharmacologica Sinica.
[21] Nelson Durán,et al. New aspects of nanopharmaceutical delivery systems. , 2008, Journal of nanoscience and nanotechnology.
[22] D. Hauss. Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.
[23] X. Wu,et al. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. , 2007, Advanced drug delivery reviews.
[24] W. Vilegas,et al. Effect of Mouriri pusa extracts on experimentally induced gastric lesions in rodents: role of endogenous sulfhydryls compounds and nitric oxide in gastroprotection. , 2006, Journal of ethnopharmacology.
[25] S. Guterres,et al. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[26] M. Salem. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. , 2005, International immunopharmacology.
[27] M. Kanter,et al. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. , 2005, World journal of gastroenterology.
[28] B. Ali,et al. Pharmacological and toxicological properties of Nigella sativa , 2003, Phytotherapy research : PTR.
[29] S. Saleh,et al. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. , 2003, Journal of ethnopharmacology.
[30] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[31] B. Nyassé,et al. Gastric cytoprotective anti-ulcer effects of the leaf methanol extract of Ocimum suave (Lamiaceae) in rats. , 2002, Journal of ethnopharmacology.
[32] F. Bucar,et al. Antioxidant activity of Nigella sativa essential oil , 2000, Phytotherapy research : PTR.
[33] R. Müller,et al. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] M. Lacaille‐Dubois,et al. [Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat]. , 2000, Therapie.
[35] Y. Raji,et al. Methyl angolensate: the antiulcer agent of the stem bark of Entandrophragma angolense. , 1995, Planta medica.
[36] J. Hunter,et al. Epidermal growth factor stimulates synthesis and secretion of mucus glycoproteins in human gastric mucosa. , 1990, Clinical science.
[37] J. Crow. Electron Microscopy in Human Medicine , 1981 .
[38] N. Seetapan,et al. Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). , 2010, Micron.
[39] Peeyush Kumar,et al. A REVIEW ON NOVEL LIPID BASED NANOCARRIERS , 2010 .
[40] Robert Blumenthal,et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.
[41] N. K. Jain,et al. Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori. , 2008, Journal of drug targeting.
[42] O. Behmer,et al. Manual de técnicas para histologia: normal e patológica , 2003 .
[43] J. Wallace,et al. The roles of ethanol and of acid in the production of gastric mucosal erosions in rats , 1981, Virchows Archiv. B, Cell pathology including molecular pathology.